Artificial intelligence methods may help in unveiling information that is hidden in high-dimensional oncological data. Flow cytometry studies of haematological malignancies provide quantitative data with the potential to be used for the construction of response biomarkers. Many computational methods from the bioinformatics toolbox can be applied to these data, but they have not been exploited in their full potential in leukaemias, specifically for the case of childhood B-cell Acute Lymphoblastic Leukaemia. In this paper, we analysed flow cytometry data that were obtained at diagnosis from 56 paediatric B-cell Acute Lymphoblastic Leukaemia patients from two local institutions. Our aim was to assess the prognostic potential of immunophenotypi...
Background: Flow cytometry analysis is the method of choice for the differential diagnosis of hemato...
Accurate risk assignment in childhood acute lymphoblastic leukaemia is essential to avoid under- or ...
Flow cytometry may be used to detect minimal residual disease (MRD) in acute lymphoblastic leukemia ...
Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high survival rates,...
Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high survival rates,...
Acute lymphoblastic leukaemia (ALL) is the most frequent childhood malignancy. One of the recent imp...
Precursor B-acute lymphoblastic leukemia (pB-ALL) is a heterogeneous disease and multiparameter flow...
Precursor B-acute lymphoblastic leukemia (pB-ALL) is a heterogeneous disease and multiparameter flow...
B-cell Non-Hodgkin lymphomas (B-NHL) are a wide and highly heterogeneous group of malignancies, char...
Flow cytometry is an important diagnostic tool in childhood acute lymphoblastic leukemias (ALL), flo...
Introduction: Several studies have focused on the immunophenotype of the leukemic population at the ...
Background: The International Prognostic Index (IPI) is applied to predict the outcome of chronic ly...
Minimal residual disease evaluation by multiparametric flow cytometry is an alternative approach to ...
Introduction: In a previous study, we demonstrated that Artificial Intelligence (AI), applied to a w...
Objectives Multiparametric flow cytometry (MFC) aids in the diagnosis and management of B-cell acute...
Background: Flow cytometry analysis is the method of choice for the differential diagnosis of hemato...
Accurate risk assignment in childhood acute lymphoblastic leukaemia is essential to avoid under- or ...
Flow cytometry may be used to detect minimal residual disease (MRD) in acute lymphoblastic leukemia ...
Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high survival rates,...
Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high survival rates,...
Acute lymphoblastic leukaemia (ALL) is the most frequent childhood malignancy. One of the recent imp...
Precursor B-acute lymphoblastic leukemia (pB-ALL) is a heterogeneous disease and multiparameter flow...
Precursor B-acute lymphoblastic leukemia (pB-ALL) is a heterogeneous disease and multiparameter flow...
B-cell Non-Hodgkin lymphomas (B-NHL) are a wide and highly heterogeneous group of malignancies, char...
Flow cytometry is an important diagnostic tool in childhood acute lymphoblastic leukemias (ALL), flo...
Introduction: Several studies have focused on the immunophenotype of the leukemic population at the ...
Background: The International Prognostic Index (IPI) is applied to predict the outcome of chronic ly...
Minimal residual disease evaluation by multiparametric flow cytometry is an alternative approach to ...
Introduction: In a previous study, we demonstrated that Artificial Intelligence (AI), applied to a w...
Objectives Multiparametric flow cytometry (MFC) aids in the diagnosis and management of B-cell acute...
Background: Flow cytometry analysis is the method of choice for the differential diagnosis of hemato...
Accurate risk assignment in childhood acute lymphoblastic leukaemia is essential to avoid under- or ...
Flow cytometry may be used to detect minimal residual disease (MRD) in acute lymphoblastic leukemia ...